Inside the Issue: Exploring the Current and Future Management of High-Risk, Hormone-Sensitive Nonmetastatic Prostate Cancer

Dr Neal Shore from the Carolina Urologic Research Center in Myrtle Beach, South Carolina, and Dr Mary-Ellen Taplin from the Dana-Farber Cancer Institute in Boston, Massachusetts, discuss the current and future management of high-risk, hormone-sensitive nonmetastatic prostate cancer.

Episode metadata supplied by the publisher feed · Published Sep 1, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

Inside the Issue: Exploring the Current and Future Management of High-Risk, Hormone-Sensitive Nonmetastatic Prostate Cancer

0:00 1:01:01

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Prostate Cancer Update?

This episode is 1 hour and 1 minute long.

When was this Prostate Cancer Update episode published?

This episode was published on September 1, 2023.

Can I download this Prostate Cancer Update episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!